Genetic control of skeletal development

Current Opinion in Genetics and Development

Volumn 11, Issue 5, 2001, Pages 527-532

  Wagner, Erwin F ^a   Karsenty, Gerard ^b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b Baylor College of Medicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; BIOCHEMISTRY; BONE; BONE DEVELOPMENT; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL SPECIFICITY; CELL TYPE; GENETIC REGULATION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REVIEW; SKELETON;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CARTILAGE; CELL DIFFERENTIATION; CHONDROCYTES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; OSTEOBLASTS; OSTEOCLASTS;

EID: 0035479838     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00228-8     Document Type: Review

References (59)

1. Chondrogenesis just ain't what it used to be
2. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
3. Conditional inactivation of VEGF-A in areas of collagen2a1 expression causes embryonic lethality in the heterozygous state
4. Matrix Metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
5. Sox9 is required for cartilage formation
6. FGFs, heparan sulfate and FGFRs: Complex interactions essential for development
7. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene
8. PTh/PThrP receptor in early development and Indian hedgehog-regulated bone growth
9. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein
10. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation
11. Continuous expression of Cbfa1 in non-hypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice
12. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes
13. Maturational disturbance of chondrocytes in Cbfa1-deficient mice
14. Regulation of chondrocyte differentiation by Cbfa1
15. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
16. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblast
17. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
18. The osteoblast: A sophisticated fibroblast under central surveillance
19. Missense mutations abolishing DNA binding of the osteoblast specific transcription factor OSF2/Cbfa1 in cleidocranial dysplasia
20. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
21. Vertebrate Hedgehog signaling modulated by induction of a Hedgehog-binding protein
22. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation
23. AP-1 in mouse development and tumorigenesis
24. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1
25. Overexpression of deltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis
26. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoter
27. Bone L formation by autoinduction
28. TGF-β signalling from cell membrane to nucleus through SMAD proteins
29. Negative regulation of BMP/Smad signaling by Tob in osteoblasts
30. Bone resorption by osteoclasts
31. Regulation of the differentiation and function of osteoclasts
32. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
33. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
34. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1
35. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
36. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
37. Fra-1 replaces c-Fos-dependent functions in mice
38. Placental vascularisation requires the AP-1 component Fra1
39. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
40. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
41. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
42. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
43. Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption
44. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
45. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
46. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
47. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors
48. RANK is essential for osteoclast and lymph node development
49. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
50. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice
51. Receptor activator of NF-κB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase
52. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-g
53. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis
54. Loss of the C1C-7 chloride channel leads to osteopetrosis in mice and man
55. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis
56. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification
57. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants
58. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass